Medivolve Inc MEDVF

When you calculate revenue & profit .40 is nothing

[Sarb99]

Just go with 32 testing sites up and running with the last tests per day performed guidance from the company. 32x94 =3008 testing per day can generate 3008x$95=$285,760 and then convert USD to CAD $285,760 x1.29=$368,630. Now 368,630x30=$11,058,912 per month and $132,706,944 per year. 

 

Now calculate the company projected EBITDA of 55%, and you get $72.9 Million, which is more than the current market cap itself. Once you start using the stock market standard, PE Ratio. You will quickly realize .40 cents per share price is nothing. Start using a PE Ratio of 5-10-15 and see where QSC should be in reality. 

 

Now talk about another 13 testing sites coming online in a few days. The next phase is bringing another 63 testing sites by the end of January. These are 76 additional testing sites. Now calculate the revenue from these 76 testing sites, and you will see .40 cents is nothing. 

 

Now imagine the end of March or April with 500 to 700 testing sites. It seems smart money scooping up these shares from penny pinchers. 

[fuquebec]

This post has been removed in accordance with Community Policy

[maidenmist]

Sarb: We all know that people sign off with M.P.O. Indeed that is the case. SO, what I'm asking is, based on the numbers you have thrown around, in your conservative opinion, what should the stock price be? Can you see a SONA in the works where she runs to 16 in 7 months? Love to hear your take on it. You seem quite knowledgable in your assesment, hence me reaching out to you. Thanks in

[CerealKiller]

You, Sir, are far too obsessed with SONA and their (brief) $16 share price. Despite both being largely Covid plays, the companies are not similar. Medivolve probably has more potential actually, but to keep harping on about matching SONA's (irrational) run up is fanciful and is only going to lead to disappointment.

[RockThunder]

Cerealkiller ,,exactly the kind of talking i like ,good call

[Sarb99]

QuestCap and Sona are two different companies with different business models. SONA developed Antigen testing kits and ran to $16, investors thinking "Sona" to get approval by Health Canada and EUA. That never happened, and it came crashing back to a Dollar. Now up again to $4 on CE in Europe approval. SONA share price goes up or down, based on speculation, not based on earned revenue